Search Results

You are looking at 101 - 110 of 561 items for :

  • Refine by Access: All x
Clear All
Full access

QIM24-187: Determining the Most Appropriate FIT to Increasing Colorectal Cancer Screening in the Community

Nikita Dahake, Brianna Graham, Gabrielle Gillow, Shelby McNeilly, Abraham Ifrah, Manasa Vallabhaneni, Christopher Grivas, Rishab Khatri, and Claire Raab

. Patients may also have a component of treatment fatigue associated with the hospital. Moreover, we found that patients responded more to preventative outreach via text messages over phone calls. Patients may feel that texting is a private way to talk about

Full access

HSR20-082: Use of the NCCN Distress Thermometer to Identify and Address Distress During a Telemedicine Visit With Rural Head and Neck Cancer Survivors

Pam Baker DeGuzman, Veronica Bernacchi, C. Allen Cupp, B. J. Ferrebee Ghamandi, Ivora D. Hinton, Mark J. Jameson, Debra Lynn Lewandowski, and Christi Sheffield

16 participants, the most common issues identified were fatigue (69%), worry (63%), family health issues (56%) and hearing loss (56%). Although only 3 participants identified jaw swelling as an issue, this was the most highly rated area of distress on

Full access

HSR20-076: Provider Versus Patient Reported Outcomes (PROs) in Colorectal Cancer (CRC) Patients (pts) Undergoing Systemic Therapy (Ctx): A Real World Experience

Sonali Agrawal, Caitlin R. Meeker, Sandeep Aggarwal, Elizabeth A. Handorf, Sunil Adige, Efrat Dotan, Crystal S. Denlinger, William H. Ward, Jeffrey M. Farma, and Namrata Vijayvergia

(others were on clinical trials with novel agents). Most common grade 3+ tox reported by providers included nausea (10%) and neuropathy (8%), while the common clinically significant tox reported by pts were neuropathy (20%), fatigue (20%), and anxiety (15

Full access

HSR20-106: Quantifying Patient Preferences for Attributes Associated With First-Line Treatment of Metastatic Non-Small Cell Lung Cancer

Brian Seal, Candice Yong, M. Janelle Cambron-Mellott, Oliver Will, Martine C. Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla, and Ranee Mehra

%, and all G neuropathy from 5% to 39%, if OS increased by 17, 4, and 2 months, respectively. In addition, pts would require an increase in OS of 1 month to accept an increase in G3/4 fatigue from 1% to 12% or all G pneumonitis from <1% to 8%. Preferences

Full access

CLO22-056: Phase I Trial of Concurrent Nab-paclitaxel and Cisplatin With Radiotherapy for Locally Advanced Cervical Cancer

Ping Jiang, Ang Qu, Weijuan Jiang, Xiuwen Deng, and Junjie Wang

twice a week. Dose escalation followed a 3 + 3 design. The DLT was defined as grade 3 or 4 nonhematologic toxicity, excluding nausea, vomiting and alopecia, decreased appetite and fatigue, or grade 4 hematologic toxicity. Results : This study was

Full access

QIM21-084: Perceived Needs and Patient Satisfaction of Psychosocial Distress Screening and Management in Inpatient Hematology Oncology Specialty Care

Chao-Hui Sylvia Huang, Jennifer K. Anderson, Jasmine A. Boykin, Jasmine K. Vickers, Heather Forbes, Kellie L. Flood, Lisle M. Nabell, and Kelly N. Godby

strategies to manage anxiety or depression. Barriers to receive counseling services include physical symptom burden such as pain and fatigue, medical procedures, and inadequate psychosocial care staffing. Findings revealed high perceived needs and patient

Full access

CLO22-065: Treatment Failure and Transition to Next-Line Therapy in Myelofibrosis: A Modified Delphi Panel Approach

John Mascarenhas, Arianna Kee, Hiep Nguyen, Ashley Saunders, Louisa Oliver, Hannah Tomkinson, Richard Perry, and Ali McBride

consensus statements suggest patient-reported symptoms of fatigue, poor concentration, inactivity, and bone pain were too general to define RUX failure compared with other specific MF symptoms ie, night sweats. Following RUX failure, consensus

Full access

HSR24-139: Patient-Reported Outcome Measures Used in Patients With Chronic Phase–Chronic Myeloid Leukemia: A Systematic Review of the Literature

Kathryn E. Flynn, Lovneet Saini, Aditi Kataria, Kejal Jadhav, Daisy Yang, and David Wei

health or QoL were reported in 50% of studies, whereas symptom-specific scores (eg, fatigue and gastrointestinal symptoms) were reported in 26% of studies. Longitudinal changes were reported in 11 studies; 4 studies reported direct comparisons of

Full access

BPI23-010: The Benefits of a Clinically Based Individualized Exercise Oncology Program on Health Care Utilization in Patients With Malignancies

Karen Wonders, Jay K Harness, and Arthur G Lerner

Specifically, cardiovascular endurance, muscular strength, quality of life, depression, fear, fatigue, and pain all significantly improved following the exercise intervention (p<0.05). On average, each patient exhibited 2.81 fewer encounters following exercise

Full access

BPI22-020: Better Together: Why Palliative Care Should be Incorporated Early in Patients With Advanced Head and Neck Cancer

Vishal Kapadia, Elisa Griswold, Kelley Newcomer, Brittny Tillman, Jane Mwangi, and Stephanie Terauchi

diagnosis. Pain was the most distressing symptom, where 13/21 patients had severe pain with an average modified ESAS score of 6. Fatigue, odynophagia, sense of wellbeing, and dysphagia were amongst the other symptoms with average modified ESAS scores of ≥4